- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
UPDATED May 02, 2024
High return on equity, past performance and sound balance sheet.
79 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
6817 | NT$127.00 | 0.4% | 46.0% | NT$2.3b | n/a | PE14.7x | n/a | 5.2% | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | ||
688578 | CN¥62.08 | 9.5% | 132.5% | CN¥27.9b | n/a | PE30.5x | E5.1% | n/a | ||
688506 | CN¥154.66 | 7.1% | 62.4% | CN¥62.0b | CN¥158.00 | PE14.1x | E-101.1% | 0% | ||
688621 | CN¥56.35 | -0.8% | -11.2% | CN¥6.3b | n/a | PE30.1x | E38.9% | 0.3% | ||
6620 | NT$122.00 | -6.5% | -28.7% | NT$17.2b | NT$200.00 | PE23.7x | n/a | 0.8% | ||
OBSN | CHF0.0052 | -40.9% | -93.7% | CHF609.3k | n/a | PE0.08x | n/a | n/a |